Serological approaches to subtyping of HIV-1 in injecting drug users in Russia: Evidence of subtype homogeneity at the main sites of the epidemic

International Journal of STD and AIDS

Volumn 12, Issue 1, 2001, Pages 34-40

  Bobkova, M R ^a   Kazennova, E V ^b   Selimova, L M ^b   Buravtsova, E V ^a   Lister, S ^c   Prilipov, A G ^b   Weber, J N ^c   Pokrovsky, V V ^a   Bobkov, A F ^b  

^a Federal AIDS Centre   (Russian Federation)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Genetic subtypes; HIV 1; Injecting drug users; Russia; Serotyping; Synthetic peptides

Indexed keywords

GLYCOPROTEIN GP 120; PEPTIDE DERIVATIVE;

ARTICLE; ENZYME IMMUNOASSAY; EPIDEMIC; HETERODUPLEX ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; RECOMBINANT GENE; RUSSIAN FEDERATION; SEROTYPE; VIRUS GENE; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TYPING;

AMINO ACID SEQUENCE; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HETERODUPLEXES; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; RUSSIA; SEROTYPING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0035150513     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462011916712     Document Type: Article

References (23)

1. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O
2. Recombination in HIV-1
3. Genetic relationships determined by a DNA heteroduplex mobility assay analysis of HIV-1 env genes
4. Rapid genetic characterization of HIV type 1 strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. WHO Network for HIV Isolation and Characterization
5. Genetic heterogeneity of HIV type 1 in Russia: Identification of H variants and relationship with epidemiological data
6. An HIV type 1 epidemic among injecting drug users in the former Soviet Union caused by a homogeneous subtype A strain
7. Serotyping HIV type 1 by antibody binding to the V3 loop: Relationship to viral genotype. WHO network for HIV isolation and characterization
8. Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO network for HIV isolation and characterization
9. Serotyping of HIV type 1 infections: Definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization
10. Highly specific peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand
11. Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand
12. An association between HIV-1 subtype and risk group in Cape Town, South Africa
13. Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: Evidence of increasing infection with HIV-1 subtype E
14. The determinants of the spread of HIV among injection drug addicts in Ukraine
15. An analysis of an outbreak of HIV infection in the city of Svetlogorsk, the Republic of Byelarus, among persons using injected narcotics
16. Epidemiological trends of AIDS and other sexually transmitted diseases in the eastern part of Europe
17. A sudden epidemic of HIV type 1 among injecting drug users in the former Soviet Union: Identification of subtype A, subtype B, and novel gagA/envB recombinants
18. Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine
19. HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad
20. Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus
21. HIV-1 V3 serotypes: Distribution and correlation with genotypes